(Q34154802)

English

Phase 1 trial of the novel bispecific molecule H22xKi-4 in patients with refractory Hodgkin lymphoma

scientific article

Statements

Phase 1 trial of the novel bispecific molecule H22xKi-4 in patients with refractory Hodgkin lymphoma (English)
1 November 2002
3101-3107

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit